false 0000021076 0000021076 2024-11-20 2024-11-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 20, 2024

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)

 
Delaware 1-07151 31-0595760
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation)   Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
   
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading
Symbol(s)
Name of each exchange on which registered
Common Stock - $1.00 par value CLX New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company     

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

  (a) On November 20, 2024, The Clorox Company (the “Company”) held its virtual annual meeting of shareholders.
     
  (b) The shareholders (1) elected all of the Company’s nominees for director, (2) approved the compensation of the Company’s named executive officers on an advisory basis, and (3) ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2025.

The final voting results on each of the matters submitted to a vote are as follows:

  1. Election of Directors:
    Number of Votes
    For Against   Abstain   Broker Non-Votes
Stephen B. Bratspies   88,574,185 420,571   210,942   17,145,925
Pierre R. Breber   88,583,063 415,714   206,922   17,145,925
Julia Denman   88,472,706 543,421   189,572   17,145,925
Spencer C. Fleischer   87,205,016 1,796,214   204,469   17,145,925
Esther Lee   85,346,195 3,664,298   195,206   17,145,925
A.D. David Mackay   88,390,870 612,443   202,385   17,145,925
Stephanie Plaines   88,432,195 587,490   186,014   17,145,925
Linda Rendle   84,229,786 4,419,727   556,185   17,145,925
Matthew J. Shattock   87,379,925 1,623,635   202,138   17,145,925
Russell J. Weiner   88,356,468 636,204   213,027   17,145,925
Christopher J. Williams   87,694,853 1,305,769   205,076   17,145,925
  2. Advisory Vote on the Approval of Named Executive Officers Compensation:
Number of Votes
For   Against   Abstain   Broker Non-Votes
83,241,298   5,474,458   489,942   17,145,925
  3. Ratification of the selection of Ernst & Young LLP as the Company’s independent auditor for 2025.
Number of Votes
For   Against   Abstain   Broker Non-Votes
101,119,064   4,974,815   257,744   0

2

 

Item 8.01 Other Events.

On November 20, 2024, the shareholders of the Company elected Stephen B. Bratspies and Pierre R. Breber to the Board of Directors of the Company. A press release announcing the election of Messrs. Bratspies and Breber is filed as Exhibit 99.1 and is incorporated herein in its entirety.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

See the Exhibit Index below.

EXHIBIT INDEX

Exhibit   Description
     
99.1   Press Release dated November 20, 2024 of The Clorox Company
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

3

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    THE CLOROX COMPANY
 
Date:  November 21, 2024 By:  /s/ Angela Hilt
      Angela Hilt
      Executive Vice President – Chief Legal Officer
and Corporate Secretary

 

4

 

Exhibit 99.1

PRESS RELEASE    

Clorox Announces Election of Stephen Bratspies
and Pierre Breber to its Board of Directors

OAKLAND, Calif., November 20, 2024 — The Clorox Company (NYSE: CLX) today announced the election of Stephen Bratspies and Pierre Breber, effective as of today, to its board of directors, adding deep leadership, operational and financial experience that aligns with Clorox’s strategic priorities.

Bratspies, 57, brings strong executive leadership experience, including as chief executive officer of Hanesbrands. He also holds considerable operational, merchandising and marketing expertise from senior leadership roles with Walmart, Specialty Brands and PepsiCo. Bratspies’ significant customer, retail and consumer packaged goods industry background enables him to provide valuable perspective on the Company’s strategy, business and growth. Bratspies also serves on the Board of Hanesbrands.

Breber, 60, brings extensive financial and accounting expertise, including as chief financial officer at Chevron where he held numerous executive, commercial, operational and international leadership roles. He also possesses broad experience in strategic transformation and growth initiatives, which support Clorox’s strategic objectives. Breber also serves on the Boards of PACCAR and Southwest Airlines.

“We are honored to add Stephen and Pierre and their exceptional experience to our Board,” said Linda Rendle, chair and chief executive officer of The Clorox Company. “Their fresh perspectives and deep backgrounds in driving enterprise growth and transformation will be an immense asset as we continue advancing Clorox’s strategy for long-term value creation.”

Bratspies is expected to serve on the Audit committee and Breber is expected to serve on the Audit and the Nominating, Governance and Corporate Responsibility committees. As previously disclosed in Clorox’s proxy statement, Amy Banse, Paul Parker and Kathryn Tesija did not stand for re-election at the annual meeting of stockholders. All other nominees were elected to new terms as directors. This now brings the current number of Board members to 11.

Additional information about The Clorox Company board of directors can be found at www.thecloroxcompany.com

About The Clorox Company

The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its

 

 

trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well as international brands such as Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first in the U.S. to integrate ESG into its business reporting. In 2024 the company was ranked No. 1 on Barron’s 100 Most Sustainable Companies list for the second consecutive year. Visit thecloroxcompany.com to learn more.

CLX-C

Contacts:

Media Relations:

corporate.communications@clorox.com

Investor Relations:

investorrelations@clorox.com

 

v3.24.3
Cover
Nov. 20, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Nov. 20, 2024
Entity File Number 1-07151
Entity Registrant Name THE CLOROX COMPANY
Entity Central Index Key 0000021076
Entity Tax Identification Number 31-0595760
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1221 Broadway
Entity Address, City or Town Oakland
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94612-1888
City Area Code 510
Local Phone Number 271-7000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock - $1.00 par value
Trading Symbol CLX
Security Exchange Name NYSE
Entity Emerging Growth Company false

Clorox (NYSE:CLX)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Clorox.
Clorox (NYSE:CLX)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Clorox.